Omnicell, Inc.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Randall A. Lipps
- Full Time Employees
- 3,525
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Address
- 4220 North Freeway Fort Worth TX United States of America 76137
- IPO Date
- Aug 7, 2001
- CIK
- 0000926326
- Website
- omnicell.com
- Similar Companies
- Business
- Omnicell, Inc. is a healthcare technology company specializing in medication management solutions and adherence tools designed to enhance healthcare delivery and operational efficiency. The company offers an extensive portfolio that includes automated medication dispensing systems; pharmacy automation equipment; medication adherence packaging; analytics and inventory management software; point-of-care pharmacy automation; adherence packaging systems under the MyMD packaging brand; and clinical decision support applications. Omnicell serves healthcare providers, pharmacies, hospitals, and long-term care facilities across the United States, Canada, and select international markets. Founded in 1992, the company is headquartered in Mountain View, California. In the past 1-2 years, Omnicell has focused on expanding its clinical and financial analytics capabilities, integrating new software enhancements to improve medication safety and operational workflows. The company has also been active in strategic partnerships that broaden its technology ecosystem and has launched updated versions of its adherence packaging solutions. Omnicell continues to extend its presence in the pharmacy automation market through selective acquisitions and innovation in medication management systems. These initiatives reflect a strategic shift toward comprehensive service offerings that combine hardware, software, and analytics to support a data-driven approach in healthcare operations. Omnicell operates primarily in the healthcare technology and medical devices industry, targeting hospital systems, health systems, retail pharmacies, and senior care providers. Its product and service offerings are designed to address challenges in medication adherence, reduce medication errors, optimize pharmacy workflows, and improve patient outcomes. The company maintains a broad geographic footprint across North America with growing influence internationally, supported by its network of subsidiaries and partners specializing in healthcare technology solutions.
Is Omnicell Inc (OMCL) a Bargain After 4.7% Drop? GF Value Says Undervalued
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
Dimensional Fund Advisors LP Acquires 137,834 Shares of Omnicell, Inc. $OMCL
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
Omnicell Q2 Earnings Call Highlights
Omnicell, Inc. (OMCL) Q2 2026 Earnings Call Transcript
Omnicell (OMCL) Q2 Earnings and Revenues Top Estimates
Omnicell Announces Second Quarter 2026 Financial Results
Omnicell to Report Q2 Earnings: OmniSphere in Focus
Should You Continue to Hold OMCL Stock in Your Portfolio Now?
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?
Nnamdi Njoku Appointed President of Omnicell
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Do Options Traders Know Something About Omnicell Stock We Don't?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Omnicell: Why I'm Long Into Q2 Earnings Despite The Bookings Wobble
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business